RxDoctor Payments Data

Jillian Nelson

Nurse Practitioner · Munster, INNPI 1891244828

Payments from drug & device makers

$383in general payments, 2019–2025

Across 15 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$114
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$84
  • Insulet Corporation$51
  • Abbott$47
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • Exact Sciences$23
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$383 in reported general payments places this provider in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$10,177
Medicare patients
64
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$168,195
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$67,845
EntrestoSacubitril/Valsartan33$58,663
TrulicityDulaglutide31$54,828
JardianceEmpagliflozin43$50,213
FarxigaDapagliflozin Propanediol31$38,546
JanuviaSitagliptin Phosphate30$36,012
MounjaroTirzepatide15$24,340
Breo ElliptaFluticasone/Vilanterol26$20,271
EliquisApixaban20$17,751
XareltoRivaroxaban17$16,676
LinzessLinaclotide11$14,618
SymbicortBudesonide/Formoterol Fumarate24$8,577
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$6,723
Albuterol Sulfate HfaAlbuterol Sulfate167$5,574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$114$168,19591 claims
Lilly USA, LLCTrulicity, Mounjaro$16$79,16946 claims
AbbVieLinzess$20$14,61811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →